BIOLARGO, INC. - 8-K Filing

BioLargo subsidiary Clyra Medical reports commercial traction for ViaCLYR® wound irrigation solution following March 2026 launch. (Items: 7.01 Regulation FD Disclosure, 9.01 Financial Statements and Exhibits)

2 articles from 1 source · updated November 3, 2026, 16:35 UTC

Coverage

• Carter Bankshares, Inc. - 8-K Filing SEC EDGAR · November 3, 2026, 16:34 UTC
• BIOLARGO, INC. - 8-K Filing SEC EDGAR · November 2, 2026, 11:20 UTC